Skip to content
Lower risk Medical device recall · FDA · Published April 3, 2026

Depuy ATTUNE Revision Hinge Femoral LT SZ 8 CEM: Sterility Packaging Risk

Depuy recalls ATTUNE Revision Hinge Femoral LT SZ 8 CEM (Part 150450108) due to potential sterility compromise from packaging adhesion. Affected units have specific lot numbers and expiration dates.

🇺🇸 FDA recall #Z-1988-2026Medical deviceDepuy ›
Take action

Contact the company

Recalling firmDEPUY (IRELAND)Loughbeg, Ringaskiddy · Co. Cork, Ireland
✎ GovInfoNow plain-language explainer

What happened, in plain English

Depuy is recalling a specific hip implant part because its sterile packaging might stick together, risking infection during surgery. This affects patients who received this exact model with the listed part number. Read more at govinfonow.com/recall/49542-depuy-attune-revision-hinge-femoral-lt-sz-8-cem-sterility.

Source Summary by GovInfoNow · govinfonow.com/recall/49542-depuy-attune-revision-hinge-femoral-lt-sz-8-cem-sterility · Updated August 17, 2026 · FDA enforcement record: FDA #Z-1988-2026

Cite this page

“Depuy ATTUNE Revision Hinge Femoral LT SZ 8 CEM: Sterility Packaging Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/49542-depuy-attune-revision-hinge-femoral-lt-sz-8-cem-sterility. Based on FDA recall #Z-1988-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1988-2026%22&limit=1).

Why it’s dangerous

The external sterile packaging can stick to the internal sterile packaging, which might compromise the sterility of the implant during surgery. This could lead to infection if the implant is not properly sterile.

Who’s affected

Patients who received this specific hip implant part during surgery are affected. Surgeons and hospitals using this part for procedures are most at risk.

How to tell if you have this one

Check for the part number 150450108 on the packaging. Affected units have lot number AF1006441 and expire by December 31, 2035.

  • Brand
    Depuy
  • Category
    Medical device
FDA recall event · 9 products

All 9 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    US Nationwide distribution in the states of MN, NC, TX.
Recall numberProduct, codes & lots
Z-1985-2026Depuy Synthes, ATTUNE REVISION HINGE FEMORAL LT SZ 4 CEM. Part Number: 150450104.; Part Number: 150450104. UDI-DI: 10603295533115. Lot Number: 1007844. Expiration Date: 11/30/2035
Z-1986-2026Depuy Synthes, ATTUNE REVISION HINGE FEMORAL LT SZ 5 CEM. Part Number: 150450105.; Part Number: 150450105. UDI-DI: 10603295533122. Lot Number: AF1007829. Expiration Date: 12/31/2035.
Z-1987-2026Depuy Synthes, ATTUNE REVISION HINGE FEMORAL LT SZ 7 CEM. Part Number: 150450107.; Part Number: 150450107. UDI-DI: 10603295533139. Lot Number: 1006440. Expiration Date: 11/30/2035.
Z-1988-2026Depuy Synthes, ATTUNE REVISION HINGE FEMORAL LT SZ 8 CEM. Part Number: 150450108.; Part Number: 150450108. UDI-DI: 10603295543022. Lot Number: AF1006441. Expiration Date: 12/31/2035.
Z-1989-2026Depuy Synthes, ATTUNE REVISION HINGE FEMORAL RT SZ 3 CEM. Part Number: 150450203.; Part Number: 150450203. UDI-DI: 10603295533146. Lot Number: 1007537. Expiration Date: 10/31/2035.
Z-1990-2026Depuy Synthes, ATTUNE REVISION HINGE FEMORAL RT SZ 4 CEM. Part Number: 150450204.; Part Number: 150450204. UDI-DI: 10603295533153. Lot Number: 1005229. Expiration Date: 10/31/2035.
Z-1991-2026Depuy Synthes, ATTUNE REVISION HINGE FEMORAL RT SZ 5 CEM. Part Number: 150450205.; Part Number: 150450205. UDI-DI: 10603295533160. Lot Number: 1006444. Expiration Date: 10/31/2035.
Z-1992-2026Depuy Synthes, ATTUNE REVISION HINGE FEMORAL RT SZ 7 CEM. Part Number: 150450207.; Part Number: 150450207. UDI-DI: 10603295533177. Lot Number: 1007046. Expiration Date: 10/31/2035.
Z-1993-2026Depuy Synthes, ATTUNE REVISION HINGE FEMORAL RT SZ 8 CEM. Part Number: 150450208.; Part Number: 150450208. UDI-DI: 10603295543039. Lot Numbers: AF1008441, AF1008028. Expiration Date: 12/31/2035.
Based on the official FDA remedy

What to do — step by step

  1. Check Packaging Details

    Look for part number 150450108, lot number AF1006441, and expiration date December 31, 2035 on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 3 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: named in the noticeNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: nationwideLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: named in the noticeTXFlorida: nationwideFL

FDA distribution: “US Nationwide distribution in the states of MN, NC, TX.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Minnesota, North Carolina, Texas.

Recall timeline

FDA published this recall 33 days after the firm started it.

1. Firm started the recall: Apr 3, 202612. FDA classified it Class II: Apr 29, 202623. Published in FDA’s Enforcement Report: May 6, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Do I need to stop using this part?

No action is required for the part itself; the recall is for identification and potential replacement if needed.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1988-2026 (April 3, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1988-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA